Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1540-8167.2002.00839.x | DOI Listing |
World J Oncol
October 2024
Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Breast cancer is one of the most common malignancies, affecting millions of people worldwide annually. The treatment paradigm for early-stage breast cancer is in flux. The focus is now on opportunities to de-escalation treatment to minimize morbidity and maximize patients' quality of life.
View Article and Find Full Text PDFKorean Circ J
October 2024
Cardioangiologisches Centrum Bethanien (CCB) am Agaplesion Markus Krankenhaus, Frankfurt, Germany.
J Ultrasound
September 2024
Malattie Apparato Digerente, ASL Salerno, Ospedale L. Curto, Polla, Italy.
ACS Appl Mater Interfaces
June 2024
Laboratory of Adsorption and Catalysis, Department of Chemistry, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.
Engineering bulk covalent organic frameworks (COFs) to access specific morphological structures holds paramount significance in boosting their functions in cancer treatment; nevertheless, scant effort has been dedicated to exploring this realm. Herein, silica core-shell templates and multifunctional COF-based reticulated hollow nanospheres (HCOFs) are novelly designed as a versatile nanoplatform to investigate the simultaneous effect of dual-drug chemotherapy and photothermal ablation. Taking advantage of the distinct structural properties of the template, the resulting two-dimensional (2D) HCOF, featuring large internal voids and a peripheral interconnected mesoporous shell, presents intriguing benefits over its bulk counterparts for cancer treatment, including a well-defined morphology, an outstanding drug loading capability (99.
View Article and Find Full Text PDFJ Vasc Interv Radiol
September 2024
Department of Medical Imaging, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Purpose: To analyze the cost effectiveness of performing a renal mass biopsy in advance of ablation or concurrently with a percutaneous ablation procedure for the management of small renal masses (SRMs).
Materials And Methods: A decision-analytic model was developed with a cohort of 65-year-old male patients with an incidental, unilateral 1-3 cm SRM. A decision tree modeled the first year of clinical intervention, after which patients entered a Markov model with a lifetime horizon.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!